Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma

Alexander Hoellein1, Mohammad Fallahi2, Stephanie Schoeffmann1

  • 1III. Medical Department, Technische Universität München, Munich, Germany;

Blood
|August 22, 2014
PubMed

Insights

Myc overexpression drives aggressive cancers by altering protein modification. Inhibiting SUMOylation, a key process, halts Myc-driven lymphoma growth and triggers tumor regression, offering a new therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Myc oncogenic transcription factors (c-Myc, N-Myc, L-Myc) regulate cell growth, division, and metabolism.
  • Myc overexpression in cancer correlates with aggressive disease, partly via the ubiquitin-proteasome system.
  • The role of SUMOylation, a related posttranslational modification, in Myc-driven tumorigenesis was unexplored.

Purpose of the Study:

  • To investigate the role of SUMOylation in Myc-dependent tumorigenesis.
  • To determine if Myc regulates SUMOylation pathways.
  • To explore SUMOylation inhibition as a therapeutic strategy for Myc-driven lymphomas.

Main Methods:

  • Analysis of SUMOylation machinery gene expression in mouse and human Myc-driven lymphomas.
  • Genetic inhibition of SUMOylation in Myc-driven cancer models.
  • In vivo loss-of-function and pharmacologic studies.

Main Results:

  • Myc-driven lymphomas exhibit increased expression of SUMOylation regulators, leading to hyper-SUMOylation.
  • Inhibition of SUMOylation halts Myc-induced proliferation, causing cell-cycle arrest, polyploidy, and apoptosis.
  • Targeting SUMOylation leads to rapid regression of Myc-driven lymphoma in vivo.

Conclusions:

  • Myc regulates SUMOylation pathways, contributing to tumorigenesis.
  • SUMOylation is essential for Myc-driven lymphoma proliferation and survival.
  • Inhibition of SUMOylation is a promising therapeutic approach for lymphomas involving MYC.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.3K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
5.7K